{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21315265",
  "DateCompleted": {
    "Year": "2011",
    "Month": "04",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.neuron.2010.12.034"
    ],
    "Journal": {
      "ISSN": "1097-4199",
      "JournalIssue": {
        "Volume": "69",
        "Issue": "3",
        "PubDate": {
          "Year": "2011",
          "Month": "Feb",
          "Day": "10"
        }
      },
      "Title": "Neuron",
      "ISOAbbreviation": "Neuron"
    },
    "ArticleTitle": "Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans.",
    "Pagination": {
      "StartPage": "563",
      "EndPage": "571",
      "MedlinePgn": "563-71"
    },
    "Abstract": {
      "AbstractText": [
        "Investigations of fear conditioning in rodents and humans have illuminated the neural mechanisms underlying cued and contextual fear. A critical question is how personality dimensions such as trait anxiety act through these mechanisms to confer vulnerability to anxiety disorders, and whether humans' ability to overcome acquired fears depends on regulatory skills not characterized in animal models. In a neuroimaging study of fear conditioning in humans, we found evidence for two independent dimensions of neurocognitive function associated with trait vulnerability to anxiety. The first entailed increased amygdala responsivity to phasic fear cues. The second involved impoverished ventral prefrontal cortical (vPFC) recruitment to downregulate both cued and contextual fear prior to omission (extinction) of the aversive unconditioned stimulus. These two dimensions may contribute to symptomatology differences across anxiety disorders; the amygdala mechanism affecting the development of phobic fear and the frontal mechanism influencing the maintenance of both specific fears and generalized anxiety."
      ],
      "CopyrightInformation": "Copyright \u00a9 2011 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Behavioural and Clinical Neuroscience Institute, Department of Experimental Psychology, University of Cambridge, Downing Street, Cambridge, CB2 3EB, UK."
          }
        ],
        "LastName": "Indovina",
        "ForeName": "Iole",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Robbins",
        "ForeName": "Trevor W",
        "Initials": "TW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "N\u00fa\u00f1ez-Elizalde",
        "ForeName": "Anwar O",
        "Initials": "AO"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dunn",
        "ForeName": "Barnaby D",
        "Initials": "BD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bishop",
        "ForeName": "Sonia J",
        "Initials": "SJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01MH091848",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U1055.02.002.00001.01",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "093875",
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "G0001354",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "R01 MH091848",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "G120/919",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "G1000183",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Neuron",
    "NlmUniqueID": "8809320",
    "ISSNLinking": "0896-6273"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "etiology",
        "physiopathology",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Conditioning, Psychological"
    },
    {
      "QualifierName": [
        "physiology",
        "psychology"
      ],
      "DescriptorName": "Fear"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Magnetic Resonance Imaging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Photic Stimulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}